Search
for
Sort by
Research 901–930 of 1000+
- The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss
- P163 : Clinical efficacy of 2.5mg/day finasteride in female pattern hair loss
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- COMPARISION OF EFFECTS OF 2% TOPICAL MINOXIDIL SOLUTION WITH 20/0 TOPICAL PROGRESTERONE IN THE TREATMENT OF FEMALE PATTERN ANDROGENETIC ALOPECIA
- Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
- First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Male gonadal function in coeliac disease: 2. Sex hormones.
- Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
- Hair Follicle Apoptosis and Bcl-2
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Immunological characteristics and histological distribution of human hair fibrous proteins studied with anti-hair keratin monoclonal antibodies HKN-2, HKN-4, and HKN-6.
- Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
- TREATMENT OF FEMALE ANDROGENETIC ALOPECIA WITH MINOXIDIL 2%
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Sex dependent influence of a functional polymorphism in steroid 5‐α‐reductase type 2 (<i>SRD5A2</i>) on post‐traumatic stress symptoms
- Epidermal mammalian target of rapamycin complex 2 controls lipid synthesis and filaggrin processing in epidermal barrier formation
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Prostaglandin E <sub>2</sub> Receptor 2 Modulates Macrophage Activity for Cardiac Repair
- Bone morphogenetic proteins 4 and 2/7 induce osteogenic differentiation of mouse skin derived fibroblast and dermal papilla cells
- Candidate genes of SARS-CoV-2 gender susceptibility
- Anti-acne drugs in phase 1 and 2 clinical trials
- Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Contact dermatitis in reaction to 2% topical minoxidil solution